Header Logo

Connection

NEIL MCKENNA to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications NEIL MCKENNA has written about Antibodies, Monoclonal, Humanized.
NEIL MCKENNA
Connection Strength
0.146
Antibodies, Monoclonal, Humanized
  1. IL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical Psoriasis. J Invest Dermatol. 2023 09; 143(9):1689-1699.
    View in: PubMed
    Score: 0.146
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.